Rhythm Pharmaceuticals (RYTM) EBIT Margin (2021 - 2026)
Rhythm Pharmaceuticals (RYTM) posted EBIT Margin of -68.14% for Q2 2026, up 25.25 percentage points from -93.39% a year earlier and up 18.97 percentage points from the prior quarter.
Powered by 
Analysis
Rhythm Pharmaceuticals (RYTM) EBIT Margin (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT Margin at Rhythm Pharmaceuticals was -83.62%, up 29.91 percentage points year-over-year; for FY2025, it was -101.19%, up 102.84 percentage points from FY2024.
- Annual EBIT Margin has increased for four consecutive years, with a four-year change of +5290.66 percentage points (FY2021 to FY2025).
- In prior years, Rhythm Pharmaceuticals' EBIT Margin was -204.04% in FY2024 (+34.07 pp), -238.10% in FY2023 (+519.82 pp), -757.92% in FY2022 (+4633.93 pp) and -5391.85% in FY2021.
- The Q2 2026 figure stands as the highest quarterly EBIT Margin in data going back to Q1 2021.
- On a year-over-year basis, EBIT Margin has increased in each of the last nine quarters, with an average year-over-year change of +87.93 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q1 2022, with a gain of 94762.58 percentage points; the weakest was Q1 2024, with a drop of 80.68 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was -87.11% (Q1 2026), -82.20% (Q4 2025) and -102.64% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Rhythm Pharmaceuticals | 6.78 Bn | 5.65 Bn | 62.32 Mn | -68.14% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -68.14% |
| Mar 31, 2026 | -87.11% |
| Dec 31, 2025 | -82.20% |
| Sep 30, 2025 | -102.64% |
| Jun 30, 2025 | -93.39% |
| Mar 31, 2025 | -143.73% |
| Dec 31, 2024 | -98.63% |
| Sep 30, 2024 | -131.98% |
| Jun 30, 2024 | -139.20% |
| Mar 31, 2024 | -538.71% |
| Dec 31, 2023 | -170.28% |
| Sep 30, 2023 | -195.31% |
| Jun 30, 2023 | -242.46% |
| Mar 31, 2023 | -458.03% |
| Dec 31, 2022 | -478.99% |
| Sep 30, 2022 | -916.60% |
| Jun 30, 2022 | -497.42% |
| Mar 31, 2022 | -3,517.42% |
| Dec 31, 2021 | -2,806.22% |
| Sep 30, 2021 | -4,303.50% |
API Access
Rhythm Pharmaceuticals EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=RYTM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "RYTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=RYTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();